Warning letter
Innovacyn Inc.: warning letter of Jul 23, 2012
FDA warning letter 268160 · Los Angeles District Office
Key facts
| Reference number | 268160 |
|---|---|
| Company | Innovacyn Inc. |
| Subject | CGMP/New Animal Drugs/Adulterated/Unapproved |
| Issue date | Jul 23, 2012 |
| Posted date | Jul 23, 2012 |
| Issuing office | Los Angeles District Office |
| Product type | Veterinary |
| CFR sections cited | 211.198, 211.192, 211.160(b) |
| Inspection city | Rialto |
| Inspection ZIP | 92377 |
| Inspection start date | Nov 17, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: